Premium
National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?
Author(s) -
Kempf Emmanuelle,
Zalcman Gérard,
Lebbe Céleste
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33495
Subject(s) - medicine , clinical trial , melanoma , expanded access , metastatic melanoma , drug development , intensive care medicine , drug , medical physics , oncology , pharmacology , cancer research
Tailoring clinical trial methods and design according to drug class and gathering systematically long‐term real‐life clinical data from national early access programs might be options to improve the reliability of drug development in metastatic melanoma.